Jay S. Skyler
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Low-dose IL-2 in Established T1D - The "PROREG" Study (NCT03243058) | Jay S. Skyler | 2023-06-01 |
Track Jay S. Skyler automatically
Every clearance here is in the API, with alerts when new ones post.